← Eichor
Condition: Vitiligo Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Vitiligo

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients
Phase 4 · 1 location(s) · Khyber Teaching Hospital · NCT06991972Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
NA · 1 location(s) · Peking University People's Hospital · NCT07187882Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo
Phase 4 · 1 location(s) · Al-Azhar University · NCT05536856Vitiligo, New Treatment and Serum s100B
Phase 2/Phase 3 · 1 location(s) · South Valley University · NCT06768840Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers A
Phase 1 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07554222Effect of Co-enzyme Q10 and Vitamin C Alone or in Combination After a Surgical Gingival Depigmentation
NA · 1 location(s) · Al-Azhar University · NCT07677826A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo
Phase 1 · 2 location(s) · CAGE Bio Inc. · NCT07357870A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07153666PALLAS Laser for Skin Diseases
NA · 1 location(s) · Szeged University · NCT07250997A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Phase 2 · 35 location(s) · Eli Lilly and Company · NCT07533019A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo
Phase N/A · 116 location(s) · AbbVie · NCT07136467A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Effi
Phase 2 · 1 location(s) · E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. · NCT07712523Betamethasone Phonophoresis For Vitiligo
NA · 1 location(s) · Cairo University · NCT07267273National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and
Phase N/A · 2 location(s) · National Eye Institute (NEI) · NCT06491615A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · 70 location(s) · Takeda · NCT07108283Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
Phase 2 · 1 location(s) · Jiangsu vcare pharmaceutical technology co., LTD · NCT07172347Gingival Hyperpigmentation Treatment
Phase 2 · 1 location(s) · Cairo University · NCT07595705Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT
NA · 1 location(s) · Xijing Hospital · NCT06900777Study of D-2570 in Subjects With Non-Segmental Vitiligo
Phase 2 · 1 location(s) · InventisBio Co., Ltd · NCT07625891A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07251595A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vit
Phase 3 · 79 location(s) · Incyte Corporation · NCT06804811An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patien
Phase 2 · 1 location(s) · Derm Texas, PLLC · NCT07105254A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Phase 2 · 52 location(s) · Novartis Pharmaceuticals · NCT07431177A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Phase 1 · 6 location(s) · Forte Biosciences, Inc. · NCT06905873Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NA · 17 location(s) · Danish Breast Cancer Cooperative Group · NCT03646955Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06801821Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
Phase 2 · 5 location(s) · Centre Hospitalier Universitaire de Nice · NCT07152626Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo
EARLY_Phase 1 · 1 location(s) · Combined Military Hospital (CMH) institute of Medical Scienc · NCT07398807A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Phase 3 · 98 location(s) · Incyte Corporation · NCT06548360Efficacy of Upadacitinib After NECS in Vitiligo
NA · 1 location(s) · Jilin University · NCT06454461
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.